Abstract

Background:The multi-biomarker disease activity (MBDA) score is a validated test used to assess disease activity for patients with rheumatoid arthritis (RA). How it is used in clinical practice in the...

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Similar Papers

Paper Title
Journal
Date
Author
THU0087 Daily and diurnal variation and determination of the minimally important difference in rheumatoid arthritis patients with moderate to high multi-biomarker disease activity scores
D Chernoff ... Jr Curtis
Annals of the Rheumatic Diseases | VOL. 76
D Chernoff, et. al.D Chernoff ... Jr Curtis
01 Jun 2017
OP0169 A combination of proteins as measured within the multi-biomarker disease activity score at presentation of ra identifies a group of acpa-negative ra patients with high likelihood of developing dmard-free sustained remission
D.M Boeters ... T.W Huizinga
Annals of the Rheumatic Diseases | VOL. 77
D.M Boeters, et. al.D.M Boeters ... T.W Huizinga
01 Jun 2018
AB0244 Development of an adjusted multi-biomarker disease activity (MBDA) score for rheumatoid arthritis (RA) that accounts for age, sex and adiposity, with subsequent evaluation of ability to predict risk for radiographic damage
J.R Curtis ... E Hitraya
Annals of the Rheumatic Diseases | VOL. 77
J.R Curtis, et. al.J.R Curtis ... E Hitraya
01 Jun 2018
SAT0066 The Multi-Biomarker Disease Activity Score in Methotrexate Incomplete Responders Predicts Clinical Responses To Non-Biological versus Biological Therapy in Early RA
K Hambardzumyan ... R.F Van Vollenhoven
Annals of the Rheumatic Diseases | VOL. 75
K Hambardzumyan, et. al.K Hambardzumyan ... R.F Van Vollenhoven
01 Jun 2016
View more papers

More From: Annals of the Rheumatic Diseases

Paper Title
Journal
Date
Author
Itaconate is a metabolic regulator of bone formation in homeostasis and arthritis
Markus Kieler ... Stephan Blüml
Annals of the Rheumatic Diseases | VOL. -
Markus Kieler, et. al.Markus Kieler ... Stephan Blüml
10 Jul 2024
Low uveitis rates in patients with axial spondyloarthritis treated with bimekizumab: pooled results from phase 2b/3 trials
Matthew A Brown ... Irene Van Der Horst-Bruinsma
Annals of the Rheumatic Diseases | VOL. -
Matthew A Brown, et. al.Matthew A Brown ... Irene Van Der Horst-Bruinsma
08 Jul 2024
Efficacy and safety of first-line biological DMARDs in rheumatoid arthritis patients with chronic kidney disease
Yusuke Yoshimura ... Naoki Sawa
Annals of the Rheumatic Diseases | VOL. -
Yusuke Yoshimura, et. al.Yusuke Yoshimura ... Naoki Sawa
04 Jul 2024
Acod1-mediated inhibition of aerobic glycolysis suppresses osteoclast differentiation and attenuates bone erosion in arthritis
Katerina Kachler ... Aline Bozec
Annals of the Rheumatic Diseases | VOL. -
Katerina Kachler, et. al.Katerina Kachler ... Aline Bozec
04 Jul 2024
View more papers